Pepe Unchained is a new contender in the meme coin market, launching its own Layer 2 blockchain extension based on the popular Pepe coin. Recently, it has attracted considerable attention by raising ...

Gaia, a decentralized, open-source AI agent developer tool, has partnered with the restaking protocol EigenLayer to enhance decentralized AI security and scalability. According to the team ...

China is expected to play a leading role in creating a “quantum-proof” communication protocol, after scientists from the country presented a design blueprint at a major international ...

Tarsus Pharmaceuticals, Inc. (TARS) shares ended the last trading session 10.6% higher at $43.87. The jump came on an impressive volume with a higher-than-average number of shares changing hands ...

The public float for TARS is 31.79M, and currently, short sellers hold a 30.44% ratio of that floaft. The average trading volume of TARS on October 30, 2024 was 698.40K shares. 3 Tiny Stocks Primed to ...

TARS Protocol is an AI-driven, scalable Web3 modular infrastructure platform designed to empower projects with cutting-edge artificial intelligence solutions and one-stop BaaS (Blockchain-as-a-Service ...

Barclays analyst Balaji Prasad maintained a Buy rating on Tarsus Pharmaceuticals (TARS – Research Report) today and set a price target of $60.00. The company’s shares closed last Friday at $39.41.

Maye will take back the starting job whenever he's healthy enough to play (and health should be his main priority), but Maye will have to move through the protocol to replace Brissett again.